An interventional study of Direct current stimulation in Stroke, sponsored by University of Illinois at Chicago. Active, not recruiting at 1 site in United States. Open to participants aged 25 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-08-21.
Sponsored by University of Illinois at Chicago · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Stroke by University of Illinois at Chicago — 7 open to participants now, 9 under way, none of them phase 3. Stroke · University of Illinois at Chicago.
Among the 16 studies in Stroke by University of Illinois at Chicago, this one is the 7th largest by planned enrollment of the 15 interventional ones that give a count, is the only one that started in 2025, is one of 14 with no phase, and was the 15th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →7 of the 16 studies in Stroke by University of Illinois at Chicago are open now, in 1 country. Recruiting first, the newest first:
University of Illinois at Chicago · Sites in United States
Ages 18–80
University of Illinois at Chicago · Sites in United States
Ages 18–90
University of Illinois at Chicago · Sites in United States
Ages 18–90
University of Illinois at Chicago · Sites in United States
Ages 18–90
University of Illinois at Chicago · Sites in United States
Ages 18–90 · Healthy volunteers
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 25 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 1 started in 2025.
This study's planned enrollment of 50 is close to the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 46 across the 15 interventional studies, 82 across the 1 observational. Of the 7 that completed or were terminated, 2 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Illinois at Chicago is the lead sponsor of 496 studies on the registry; 115 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.
6 of the studies in Stroke by University of Illinois at Chicago that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05849532University of Illinois at ChicagoHome-based FES Training in People With Chronic Stroke | 2027-01-30 |
| NCT06127602University of Illinois at ChicagoThe REACTplusNMES Trial: A Double-blinded RCT | 2027-03-01 |
| NCT07006818University of Illinois at ChicagoImpaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function | 2027-04-30 |
| NCT04205279University of Illinois at ChicagoReactive Balance Training for Fall Prevention | 2027-05-31 |
| NCT07652970University of Illinois at ChicagoTele-CE in Severe Stroke | 2027-06 |
Add all 6 to your calendar (.ics) → With an account.
Among the 16 studies in Stroke by University of Illinois at Chicago, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Individuals with chronic stroke have long-term walking problems that limit community engagement and quality of life, lead to secondary disabilities, and increase healthcare costs and burden. These walking issues often persist despite rehabilitation. One novel target for stroke gait rehabilitation is interlimb coordination-the phase-dependent cyclical relation of the legs. Interlimb coordination is altered during walking after stroke, compromising walking stability, phase transitions, and responses to perturbation and contributing to motor compensation. It is unclear what neural pathways contribute to impaired interlimb coordination after stroke and what impact this has on walking-related outcomes.
This proposal consists of two aims to address these issues, with the long-term goal of developing therapeutic interventions to improve interlimb coordination and walking after stroke.
Aim 1 will identify which neural sources contribute to impaired interlimb coordination after stroke. During bilateral, cyclical recumbent stepping (analogue of walking), interlimb coordination will be assessed as relative leg phasing. During the task, transcranial magnetic stimulation and peripheral nerve stimulation will be applied to assess supraspinal, interhemispheric, spinal interneuronal, and sensory pathways. The relation of interlimb coordination with these outcomes will be assessed to determine potential contributors.
Aim 2 will test the association between interlimb coordination and walking after stroke. Interlimb coordination will be quantified during split-belt treadmill walking, and associations with walking speed, endurance, mobility, independence, daily activity, quality of life, and community engagement will be tested.
An additional exploratory aim will determine the effect of targeted neuromodulation on lower limb interlimb coordination. Electrical stimulation will be applied to three locations in a cross-over study: the primary motor cortex (supraspinal/interhemispheric), thoracolumbar spine (spinal interneuronal), and peripheral nerves (sensory).
Walking problems are common, disruptive, and persistent after stroke. Of 9.4 million people in the U.S. with chronic stroke, most have long-term walking problems such as decreased walking speed and endurance, and \~36% (\~3.4 million) cannot walk independently. These walking issues have secondary impacts, including limited community integration, impaired quality of life, decreased physical activity, increased risk of other diseases and disabilities, and \~$56 billion in annual costs. Hence, a major goal of stroke rehabilitation research is to improve walking. Most walking rehabilitation approaches have focused on restoring neurotypical patterns in the more affected limb without regard for the less affected limb or focused on improving walking function (e.g., maximizing walking speed) without regard for how improvements are achieved. Unfortunately, walking limitations persist even after intensive rehabilitation, perhaps because these current approaches do not adequately address the complex neural control required for walking.
Interlimb coordination is essential for walking, but impaired after stroke. One construct that reflects the complex control of walking is interlimb coordination, the phase-dependent cyclical relation of the legs [and arms]. Bipedal locomotion cannot occur without interlimb coordination, and precise control is essential for stability, phase transitions, and responses to perturbations. After stroke, interlimb coordination becomes impaired. The investigators and others have shown that during bilateral, cyclical leg movements (e.g., walking and pedaling), the phase relation between the legs is abnormal and highly variable after stroke. Lower limb muscle activity has abnormal timing and amplitude that is exacerbated during bilateral movements, and ankle motor control is worse during bilateral than unilateral movement.
Impaired interlimb coordination may contribute to worsened walking-related outcomes. Impaired interlimb coordination after stroke increases metabolic cost of walking, compromises responses to perturbation, and contributes to detrimental behaviors like motor compensation. However, it is unclear how impaired interlimb coordination impacts walking. Some studies have shown that impaired interlimb coordination is related to reduced walking speed (or pedaling velocity), but others have found no association. Although the relation of walking with interlimb coordination is unclear, related constructs (spatiotemporal asymmetry and variability) are associated with walking. Spatiotemporal asymmetry is associated with motor impairment and slower walking, and spatiotemporal variability is related to fall risk and reduced community ambulation.
Interlimb coordination is a distinct construct that is understudied. One reason why few studies have investigated interlimb coordination after stroke is that much prior work has used walking symmetry as a measure of interlimb coordination. However, less than 50% of the variance in interlimb coordination is explained by measures of symmetry, symmetry does not reflect the phase-dependent relation between limbs, and asymmetrical movements may be appropriate and well-coordinated. These data suggest that symmetry and interlimb coordination are distinct features of gait. Also, symmetry may offer limited insight into walking; improvements in symmetry and in walking are not associated, and targeting symmetry does not benefit walking more than other approaches. In contrast, measures that fully reflect interlimb coordination patterns during walking (e.g., muscle activation, kinetic, or kinematic patterns) may better inform walking rehabilitation.
Interlimb coordination has multi-level neural control, but which neural pathways contribute to impaired interlimb coordination after stroke is unclear. During walking, interlimb coordination is controlled via supraspinal, spinal interneuronal, and sensory pathways. Supraspinal motor regions have bilateral effects via ipsilateral uncrossed (e.g., corticospinal, reticulospinal) and interhemispheric pathways. Spinal interneuronal pathways control bilateral locomotor rhythms, and interlimb sensory pathways provide essential input to supraspinal regions, spinal circuits, and motoneurons. Each pathway contributes to interlimb coordination, and there is a complex interplay between pathways. Supraspinal descending pathways modulate spinal interneuronal and sensory pathways; sensory pathways are modulated by spinal interneuronal circuits; and spinal interneuronal circuits depend on sensory inputs. Stroke causes imbalanced transcallosal pathways and altered strength of bilateral motor tracts and causes secondary changes in descending supraspinal modulation of spinal interneuronal and sensory pathways, leading to altered function of these pathways For example, crossed limb reflexes, H-reflexes, and cutaneous reflexes all have abnormal timing and amplitude during walking and pedaling after stroke, and sensory loss is common after stroke. These changes may contribute to impaired interlimb coordination and walking disability after stroke. Despite its essential role for walking, there has been minimal work that investigates interlimb coordination and seeks to identify the neural sources of impairment after stroke.
Targeting interlimb coordination may improve walking. Most walking rehabilitation approaches have focused on restoring neurotypical patterns in the more affected limb with little focus on interlimb interactions or improving walking function (e.g., maximizing walking speed) without regard for movement quality. These approaches may have achieved limited success because they ignore the essential role of interlimb coordination for walking. Yet, few interventions have targeted interlimb interactions, largely because interlimb coordination has been conflated with symmetry and can be more expensive to measure. Interventions to target interlimb coordination during walking include: 1) promoting an antiphasic interlimb pattern (e.g., using visual or audio cues); 2) stimulating coordinated bilateral responses (e.g., perturbing walking surface stiffness on a variable stiffness treadmill to evoke responses to maintain coordination and stability); and 3) augmenting interlimb phasing errors with a split-belt treadmill to elicit aftereffect improvements in coordination. Repeated interlimb coordination training may yield improvements in walking. Moreover, determining the neural sources of impaired interlimb coordination could reveal additional targets for intervention. For example, neuromodulatory stimulation of supraspinal, spinal interneuronal, and/or sensory pathways may serve as a powerful adjuvant to interlimb coordination training.
The aims of this proposal address several issues that must be resolved before interlimb coordination can be effectively targeted: 1) identifying the relative contributions of supraspinal, spinal interneuronal, and sensory pathways to interlimb coordination impairments after stroke, and 2) determining the association between interlimb coordination and walking.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
TMS exclusion criteria
PNS \& DCS exclusion criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive 2 mA direct current stimulation for 20 minutes, with the anode applied to the ipsilesional primary motor cortex and the cathode applied to the contralesional supraorbit.
Device: Direct current stimulation
Participants will receive 2 mA direct current stimulation for 20 minutes, with the anode applied to the thoracic vertebra and the cathode applied to the non-paretic shoulder.
Device: Direct current stimulation
Participants will receive 2 mA direct current stimulation for 20 minutes, with the anode and the cathode applied to the cutaneous superficial peroneal nerve.
Device: Direct current stimulation
Direct current stimulation will be applied at 2 mA for 20 minutes.
Corticomotor excitability
Transcranial magnetic stimulation (TMS) will be used to measure change in contralateral and ipsilateral corticomotor excitability of the paretic tibialis anterior, medial gastrocnemius, rectus femoris, and biceps femoris. TMS will be applied at different intensities, and the response (motor evoked potential) is measured in the paretic TMS. Corticomotor excitability will be measured as the slope of the input output curve (intensity vs. response). Higher values represent greater corticomotor excitability.
Time frame: immediately before and after immediately after the intervention
Cutaneous reflexes
A train of 5 short duration (1 ms) electrical pulses at \~300 Hz will be applied to the cutaneous superficial peroneal nerve. These pulses elicit reflex responses in muscles throughout the leg (cutaneous reflexes). Amplitude of muscle activation during stimulation will be compared to periods without stimulation.
Time frame: immediately before and after immediately after the intervention
H-reflexes
1ms electrical pulses will be applied to the deep fibular (peroneal) nerve. Two evoked potentials (M-wave and H-reflex) in the muscle that will be recorded with electromyography (EMG). Stimulations will be applied at a variety of intensities ranging from 70% of H-reflex threshold up to 120% of M-Max. M and H input-output curves will be generated. We will extract the maximal H-reflex response at any intensity (H-max), calculate the H-max/M-max ratio, and determine the slope of the ascending portion of the H-reflex curve (determined with a sigmoidal function).
Time frame: immediately before and after immediately after the intervention
Interhemispheric inhibition
Transcranial magnetic stimulation (TMS) will be applied to both hemispheres and responses (silent period duration) will be measured in the ipsilateral limb. Higher values represent greater interhemispheric inhibition.
Time frame: immediately before and after immediately after the intervention
Plan to share: Yes — All underlying data for this study will be deidentified and then will be shared.
Supporting information: Study protocol, Informed consent form, Analytic code
Time frame: All shared data will be made available at latest by the time of associated publication or at the end of the performance period, whichever comes first. As permitted by the relevant repositories, data will be made available in perpetuity, but at minimum for 10 years.
Access criteria: All data described above will be shared on UIC INDIGO and UIC Research Data Glacier, university institutional and data repositories. All shared data will be accessible via persistent unique identifiers (Digital Object Identifier [DOI]). DOIs will be referenced in any related publications.
No publications or documents are linked to this record.
Started Sep 2025 (actual). Primary completion is estimated for Apr 2027, 19 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 19 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Illinois at Chicago →